Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction

Fertility and Sterility

Volumn 94, Issue 6, 2010, Pages 2202-2207

  Kaya, Cemil ^a   Pabuccu, Recai ^a   Satroglu, Hakan ^b  

^a UFUK UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Antim llerian hormone; assisted reproduction; polycystic ovary syndrome; serum AMH

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; LEUPRORELIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG DOSE REDUCTION; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; NIDATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREDICTION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; ANTI-MULLERIAN HORMONE; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; MENSTRUAL CYCLE; OSMOLAR CONCENTRATION; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED; TIME FACTORS; YOUNG ADULT;

EID: 78049312247     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.12.002     Document Type: Article

References (43)

1. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853 861
2. C. Weenen, J.S. Laven, A.R. Von Bergh, M. Cranfield, N.P. Groome, and J.A. Visser Anti-müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol Hum Reprod 10 2004 77 83
3. P. Pigny, C. Cortet-Rudelli, C. Decanter, D. Deroubaix, B. Soudan, and A. Duhamel Elevated serum level of anti-müllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest J Clin Endocrinol Metab 88 2003 5957 5962
4. J.S.E. Laven, A.G. Mulders, J.A. Visser, A.P. Themmen, F.H. De Jong, and B.C.J.M. Fauser Anti-müllerian hormone serum concentration in normoovulatory and anovulatory women of reproductive age J Clin Endocrinol Metab 89 2004 318 323
5. C.L. Cook, Y. Siow, A.G. Brenner, and M.E. Fallat Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women Fertil Steril 77 2002 141 146
6. M.J. Chen, W.S. Yang, C.L. Chen, M.Y. wu, Y.S. Yang, and H.N. Ho The relationship between anti-müllerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome Hum Reprod 23 2008 952 957
7. P.E. Hughesdon Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis" Obstet Gynecol Surv 37 1982 59 77
8. S.A. Stubbs, K. Hardy, P.D. Silva-Buttkus, J. Stark, L.J. Webber, and A.M. Flanagan Anti-müllerian hormone protein expression is reduced during development the initial stages of follicle development in human polycystic ovaries J Clin Endocrinol Metab 90 2005 5536 5543
9. L.J. Webber, S. Stubbs, J. Stark, G.H. Trew, R. Margara, and K. Hardy Formation and early development of follicles in the polycystic ovary Lancet 362 2003 1017 1021
10. M. Das, D.J. Gillott, E. Saridogan, and O. Djahanbakhch Anti-müllerian hormone is increased in follicular fluid from stimulated ovaries in women with polycystic ovary syndrome Hum Reprod 23 2008 2122 2126
11. T. Eldar-Geva, A. Ben-Chetrit, I.M. Spitz, R. Rabinowitz, E. Markowitz, and T. Mimoni Dynamic assays of inhibin B, anti-müllerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome Hum Reprod 20 2005 3178 3183
12. M.E. Fallat, Y. Siow, M. Marra, C. Cook, and A. Carrillo Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis Fertil Steril 67 1997 962 965
13. A. La Marca, S. Malmusi, S. Giulini, L.F. Tamaro, R. Orvieto, and P. Levratti Anti-müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation Hum Reprod 19 2004 2738 2741
14. A. Hazout, P. Bouchard, D.B. Seifer, P. Aussage, A.M. Junca, and P. Cohen-Bacrie Serum anti-müllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol Fertil Steril 82 2004 1323 1329
15. D.N. Lekamge, M. Barry, M. Kolo, M. Lane, R.B. Gilchrist, and P.P. Tremellen Anti-müllerian hormone as a predictor of IVF outcome Reprod Biomed Online 14 2007 602 610
16. I.A. Van Rooij, F.J. Broekmans, C.C. Hunault, G.J. Scheffer, M.J. Eijkemans, and F.H. de Jong Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility Reprod Biomed Online 12 2006 182 190
17. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome Fertil Steril 82 Suppl 3 2004 1193 1197
18. A.H. Balen, J.S. Laven, S.L. Tan, and D. Dewailly Ultrasound assessment of the polycystic ovary: international consensus definitions Hum Reprod Update 9 2003 505 514
19. L.L. Veeck An atlas of human gametes and conceptuses: an illustrated reference for assisted reproductive technology 1999 Parthenon New York
20. L.A. Stadtmauer, S.K. Toma, R.M. Riehl, and L.M. Talbert Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors Fertil Steril 75 2001 505 509
21. J.L. Hwang, K.M. Seow, Y.H. Lin, L.W. Huang, B.C. Hsieh, and Y.L. Tsai Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pretreatment for patients with polycystic ovary syndrome: a prospective randomized study Hum Reprod 19 2004 1993 2000
22. J. Tesarik, A.M. Junca, A. Hazout, F.X. Aubriot, C. Nathan, and P. Cohen-Bacrie Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology Hum Reprod 15 2000 1396 1399
23. R. Fanchin, D.H.M. Lozano, N. Frydman, A. Gouegon, N.D. Clemente, and R. Fryman Anti-müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization J Clin Endocrinol Metab 92 2007 1796 1802
24. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum anti-müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil Steril 77 2002 468 471
25. I.A. Van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, and F.H. de Jong Serum anti-müllerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
26. R. Fanchin, L.M. Schonauer, C. Righini, J. Guibourdenche, R. Frydman, and J. Taieb Serum anti-müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3 Hum Reprod 18 2003 323 327
27. C.Y. Andersen, and A.G. Byskow Estradiol and regulation of anti-müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicle fluid J Clin Endocrinol Metab 91 2006 4064 4069
28. N. Di Clemente, B. Goxe, J.J. Remy, R. Cate, N. Josso, and B. Vigier Inhibitory effect of anti-müllerian hormone upon aromatase activity and LH receptors of granulosa cells of rat and porcine immature ovaries Endocrine 2 1994 553 558
29. B. Vigier, J.Y. Picard, D. Tran, L. Legeai, and N. Josso Production of anti-müllerian hormone: another homology between Sertoli and granulosa cells Endocrinology 114 1984 1315 1320
30. P.G. Artini, C. Battaglia, G. D'Ambrogio, A. Barreca, F. Droghini, and A. Volpe Relationship between human oocyte maturity, fertilization and follicular fluid growth factors Hum Reprod 9 1994 902 906
31. J.J. Tarin, and A. Pellicier Oocyte maturation in human in vitro fertilization programmes Ann Acad Med Sing 21 1992 492 497
32. D.G. Hammitt, C.H. Syrop, B.J. Van Voorhis, D.L. Walker, T.M. Miller, and K.M. Barud Prediction of nuclear maturity from coronal morphology: influence of embryologist experience J Asist Reprod Genet 9 1992 439 446
33. J.J. Eppig The ovary: oogenesis S.G. Hillier, H.C. Kitchener, J.P. Neilson, Scientific essential of reproductive medicine 1996 WB Saunders London 147 159
34. C. Takahashi, A. Fujito, M. Kazuka, R. Sugiyama, H. Ito, and K. Saka Anti-müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization Fertil Steril 89 2008 586 591
35. F. Cano, J.A. Garcia-Velasco, A. Millet, J. Remohi, C. Simon, and A. Pellicier Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women J Assist Reprod Genet 14 1997 254 260
36. E.M. Heijnen, M.J. Eijkemans, E.G. Hughes, J.S. Laven, N.S. Macklon, and B.C. Fauser A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome Hum Reprod Update 12 2006 13 21
37. H. Kodama, J. Fukuda, H. Karube, T. Matsui, Y. Shimizu, and T. Tanaka High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome Hum Reprod 10 1995 1962 1967
38. G. Kovacs, and C. Wood The current status of polycystic ovary syndrome Aust NZ J Obstet Gynaecol 41 2001 65 68
39. M. Ludwig, D.F. Finas, S. Al-Hasani, K. Diedrich, and O. Ortmann Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients Hum Reprod 14 1999 354 358
40. R. Homburg, D. Berkowitz, T. Levy, D. Feldberg, J. Ashkenazi, and Z. Ben-Rafael In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome Fertil Steril 60 1993 858 863
41. S.L. Fong, E.B. Baart, E. Martini, I. Schipper, J.A. Visser, and A.P. Themmen Anti-müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online 16 2008 664 670
42. T. Ebner, M. Sommergruber, M. Moser, M. Shebl, E. Schreier-Lechner, and G. Tews Basal level of anti-müllerian hormone is associated with oocyte quality in stimulated cycles Hum Reprod 21 2006 2022 2026
43. T. Silberstein, D.T. Maclaughin, I. Shai, J.R. Trimarchi, G. Lambert-Messerlian, and D.B. Seifer Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology Human Reprod 21 2006 159 163